Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
Phase 2
Not yet recruiting
- Conditions
- LARS - Low Anterior Resection Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- HEM Pharma Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT05527301
News
No news found